Skip to content

Nutritional Requirement for the Severe Trauma Patients

Nutritional Requirement for the Severe Trauma Patients

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01760135
Enrollment
61
Registered
2013-01-04
Start date
2012-11-30
Completion date
2013-11-30
Last updated
2013-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma

Keywords

trauma, nutrition, hyperglycemia

Brief summary

After severe trauma, high caloric nutrition supplement do harm on metabolic and immunologic aspects.

Interventions

DIETARY_SUPPLEMENThigh caloric nutritional supplement

high caloric nutritional supplement (25kcal/kg)

DIETARY_SUPPLEMENTlow caloric nutritional supplement

low caloric nutritional supplement(15kcal/kg)

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ISS more than 15 score * older than 20 years old * patient who need parenteral nutrition more than 5 days

Exclusion criteria

* patients who have metabolic disease except for diabetes * patients who cannot resuscitated * very low body weight (\< 40kg)

Design outcomes

Primary

MeasureTime frame
Duration of antibiotics usage (days)participants will be followed for the duration of hospital stay, an expected average of 2 week).

Secondary

MeasureTime frame
Mortalityparticipants will be followed for the duration of hospital stay, an expected average of 2 week
Number of date when is showing hyperglycemia (more than 200mg/dL)participants will be followed for the duration of hospital stay, an expected average of 2 week
Hospitals staysparticipants will be followed for the duration of hospital stay, an expected average of 2 week
ICU staysparticipants will be followed for the duration of hospital stay, an expected average of 2 week

Countries

South Korea

Contacts

Primary ContactSuk-Kyung Hong, MD., PhD.
skhong94@amc.seoul.kr82-2-3010-5989

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026